Immediate Impact
31 standout
Citing Papers
Non-small-cell lung cancer
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Works of You Lu being referenced
Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| You Lu | 292 | 239 | 32 | 57 | 22 | 321 | |
| Yvonne Ang | 184 | 224 | 53 | 76 | 31 | 354 | |
| V.R. Archer | 265 | 242 | 54 | 74 | 14 | 343 | |
| Larry Leon | 228 | 254 | 27 | 36 | 14 | 309 | |
| John Barstis | 204 | 247 | 50 | 43 | 13 | 346 | |
| Yoshiko Urata | 235 | 238 | 20 | 50 | 34 | 318 | |
| J.C.-H. Yang | 277 | 260 | 18 | 91 | 12 | 345 | |
| Ilze Bāra | 220 | 253 | 36 | 53 | 22 | 353 | |
| Annalisa Guida | 236 | 160 | 60 | 104 | 37 | 311 | |
| Kaoru Irisa | 230 | 210 | 22 | 77 | 16 | 324 | |
| Michela Lia | 239 | 142 | 32 | 109 | 15 | 314 |
All Works
Login with ORCID to disown or claim papers
Loading papers...